MISSISSAUGA, Ontario, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces the expansion of its portfolio ...
The clinical laboratory real-time PCR multiplex test was designed using Co-Dx Co-Primers™ and licensed by the CDSCO for use in diagnostic procedures SALT LAKE CITY, March 7, 2024 /PRNewswire/ -- ...
The outbreak of COVID-19 (caused by SARS-CoV-2) is currently a raging pandemic and has led to major socio-economic disruption worldwide. Since the identification of SARS-CoV-2 in the region of Wuhan, ...
LONDON--(BUSINESS WIRE)--Medical and consumer genetics testing innovator and Imperial College London spin-out, DnaNudge, today announces that it has received approval from Ghana’s Food and Drugs ...
The Association for Molecular Pathology (AMP) today published a review of the current benefits and challenges to using multiplex PCR panels for the detection of microbial pathogens from ...
Autonomous Medical Devices Incorporated (AMDI) today announced that the U.S. Food and Drug Administration has granted both ...
In this webinar, our speakers will provide an introduction into the epidemiology of influenza A/B, RSV, COVID-19, Adenovirus, Human Metapneumovirus, Rhinovirus, Enterovirus, and Parainfluenza, ...
As the COVID-19 infection continues to ravage the world, the advent of an efficient as well as the economization of the existing RT-PCR based detection assay essentially can become a blessing in these ...
Acute gastroenteritis afflicts adults of all ages, causing significant suffering and inflicting significant costs on the American healthcare system. A new study encompassing nearly 40,000 hospital ...
Please provide your email address to receive an email when new articles are posted on . The BD MAX Respiratory Viral Panel detected and differentiated between influenza A and B respiratory syncytial ...
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced ...
SYDNEY--(BUSINESS WIRE)--SpeeDx Pty. Ltd. today announced submission of their PlexPCR® RespiVirus test to the Therapeutic Goods Administration (TGA). The company anticipates clearance in time for the ...